Search Medical Condition
Please enter condition
Please choose location
 

Indianapolis, Indiana Clinical Trials

A listing of Indianapolis, Indiana clinical trials actively recruiting patient volunteers.

RESULTS

Found (498) clinical trials

Fontan Udenafil Exercise Longitudinal Assessment Trial

This study is a randomized, double-blinded, efficacy trial of the effects of udenafil vs. placebo on the background of standard therapy on maximal VO2 (ml/kg/min) from baseline to six months in adolescent survivors of the Fontan procedure. . The target sample size is 400 subjects (200 per group).

Phase

0.0 miles

Learn More »

This clinical trial is provided by Antidote. Testing prescreener

Phase

0.0 miles

Learn More »

Multi-Center Prospective Randomized Comparison of AWBAT -D vs. Xeroform or Glucan II for Treatment of Donor Sites in Burn Surgery

The purpose of this study is to evaluate AWBAT™-D compared to Xeroform™ or Glucan II™ for the treatment of donor sites in burn surgery. Primary Study Goals: - To compare the rate of healing of donor sites. - To compare patient reported perception of pain - To compare the potential ...

Phase N/A

2.36 miles

Learn More »

Zimmer MotionLoc in Distal Tibia Fractures

Primary Endpoint: - Radiographic & clinical fracture healing at 3 months post-surgery. Secondary Endpoints: - Complications - Radiologic & clinical fracture healing at 6 weeks, 3, 6, and 12 months post-surgery. - Callus size & distribution at 6 weeks, 3, 6, and 12 months post-surgery. Radiologic fracture healing is defined ...

Phase N/A

2.63 miles

Learn More »

A Pilot Study of TRV130 for the Treatment of Fracture Pain

This study is designed to evaluate the analgesic efficacy of TRV130 for the treatment of moderate to severe acute pain associated with a long bone fracture in patients presenting to the ED. The safety and tolerability of TRV130 will also be evaluated in this open-label pilot study.

Phase

2.63 miles

Learn More »

Micra Transcatheter Pacing System Post-Approval Registry

The Micra Registry is a global, prospective, observational, multi-site registry. All patients enrolled in the Micra Registry will be prospectively followed for a minimum of 9 years post implant or until registry closure. Enrolled patients will have scheduled follow-up visits at least annually or as prompted by reportable adverse events; ...

Phase N/A

2.63 miles

Learn More »

Evaluation of Efficacy and Safety of MEDI2070 in Subjects With Active Moderate to Severe Crohn's Disease

This is a four-part Phase 2b study comprised of a 16-week, double-blind, placebo-controlled, Induction Period, a 12-week double-blind, placebo-controlled, Maintenance Period, a 24-week, Open-label Period and a post-treatment 28 week observational safety follow-up period designed to evaluate the short-term efficacy and the short- and long term safety of MEDI2070 in ...

Phase

2.63 miles

Learn More »